| Financial Year |
March 31 2023 |
| Monetary Funds |
878,318,881.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,962,427.60 |
| Accounts Receivable |
828,334,475.57 |
| Advances to Suppliers |
75,553,594.84 |
| Other Receivables |
193,561,640.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
621,357,496.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,520,000.00 |
| Other Current Assets |
25,783,754.51 |
| Total Current Assets |
2,725,422,086.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
875,714.84 |
| Long-term Equity Investment |
170,657,815.65 |
| Investment Properties |
193,548,168.00 |
| Fixed Assetes |
150,785,568.80 |
| Under-construction Projects |
10,930,446.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,122,052.85 |
| R&D expenses |
17,096,702.73 |
| Goodwill |
281,744,563.44 |
| Long-Term Deferred and Prepaid Expenses |
13,219,235.00 |
| Deferred Income Tax Assets |
238,833,795.13 |
| Other Non-Current Assets |
472,566,537.12 |
| Sub-Total of Non-Current Assets |
1,762,713,073.07 |
| Total Assets |
4,488,135,159.45 |
| Short-Term Loans |
134,527,965.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
501,905,393.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,671,365.19 |
| Taxes Payable |
54,004,901.24 |
| Interest Payable |
5,427,211.22 |
| Dividend Payable |
-- |
| Other payables |
149,329,767.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,641,371,560.64 |
| Other Current Liabilities |
40,644,930.31 |
| Sub-Total of Current Liabilities |
2,795,181,528.44 |
| Long-term Loans |
197,863,775.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,402,170.14 |
| Deferred Income Tax Liabilities |
5,683,705.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
263,733,019.06 |
| Total Liabilities |
3,058,914,547.50 |
| Paid-In Capital(Or Share Stock) |
740,360,305.00 |
| Capital Surplus |
2,439,817,380.06 |
| Surplus Reserve |
59,301,191.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,867,520,101.89 |
| Minority Stockholder's Interest |
78,312,156.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,350,908,455.59 |
| Owner's Equity（Stockholder's Equity） |
1,429,220,611.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,488,135,159.45 |
